Nasdaq

Nasdaq

KAZIA ANNOUNCES RECEIPT OF NASDAQ MINIMUM BID NOTIFICATION

Sydney, Nov. 20, 2023 /PRNewswire/ -- Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused biotechnology company, announced today that it has received a notification from the Nasdaq Stock Market indicating that the company is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.

The notification has no immediate effect on the listing of Kazia's American Depositary Shares on Nasdaq. The company has until May 19, 2024 to regain compliance with the minimum bid price requirement. Kazia intends to monitor the bid price for its ADSs and consider available options to resolve the deficiency and regain compliance with Nasdaq's listing rules.